Morgan Stanley

Selected news for the capital firm - Morgan Stanley, collected since 10/2017. This capital firm shares healthcare news with Medical Research, COVID-19, Wolfe Research, Pfizer, UnitedHealth and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/12/2022 Charles River Laboratories International, Inc. (NYSE:CRL) Receives $412.69 Consensus Target Price from Analysts - Mayfield Recorder Mayfield Recorder ... CRL. Citigroup dropped their price target on shares of Charles River Laboratories International from $425.00 to $400.00 and set a “neutral” rating on the stock in a research report on Thursday, November 4th. Morgan Stanley dropped their price target on shares of Charles River Laboratories International from $480.00 to $465.00 and set an “overweight” rating on the stock in a research report on Thursday, November 4th. Evercore ISI ...
1/12/2022 MEMBERS Trust Co Has $430,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH) - The Cerbat Gem thecerbatgem.com ... hedge funds have also recently bought and sold shares of the company. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group in the second quarter valued at about $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new stake in shares of UnitedHealth Group in the second quarter valued at $28,000. Activest Wealth Management bought a new stake in shares of UnitedHealth Group during the 2nd ...
1/12/2022 UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Robertson Stephens Wealth Management LLC - Ticker Report Ticker Report ... institutional investors also recently made changes to their positions in the stock. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter worth $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new stake in shares of UnitedHealth Group in the second quarter worth about $28,000. Activest Wealth Management acquired a new position in shares of UnitedHealth Group during the 2nd ...
1/12/2022 UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Teachers Retirement System of The State of Kentucky American Banking News ... A number of other hedge funds also recently modified their holdings of UNH. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group during the second quarter worth approximately $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new position in shares of UnitedHealth Group in the second quarter valued at $28,000. Activest Wealth Management purchased a new position in UnitedHealth Group during the 2nd quarter worth ...
1/12/2022 NN Investment Partners Holdings N.V. Cuts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH) American Banking News ... and other institutional investors also recently modified their holdings of UNH. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the second quarter valued at $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new position in shares of UnitedHealth Group during the second quarter valued at about $28,000. Activest Wealth Management bought a new position in shares of UnitedHealth Group during the ...
1/12/2022 CVS Health (NYSE:CVS) Given New $116.00 Price Target at Sanford C. Bernstein thelincolnianonline.com CVS Health (NYSE:CVS) had its price objective boosted by Sanford C. Bernstein from $111.00 to $116.00 in a research note issued to investors on Tuesday, The Fly reports.A number of other equities research analysts have also recently commented on CVS. Morgan Stanley lifted their price objective on CVS Health from $115.00 to $125.00 and gave the stock an overweight rating in a research note on Monday, December 13th ...
1/12/2022 GoodRx (NASDAQ:GDRX) Stock Rating Upgraded by Zacks Investment Research dispatchtribunal.com ... November 11th. Credit Suisse Group boosted their price target on shares of GoodRx from $45.00 to $52.00 and gave the company an “outperform” rating in a research report on Tuesday, September 14th. Finally, Morgan Stanley upped their target price on shares of GoodRx from $38.00 to $41.00 and gave the stock an “equal weight” rating in a research report on Friday, December 17th. Four analysts have rated the ...
1/12/2022 GoodRx (NASDAQ:GDRX) Stock Rating Upgraded by Zacks Investment Research thelincolnianonline.com ... a research note on Wednesday, January 5th. Barclays upped their target price on GoodRx from $45.00 to $47.00 and gave the company an “overweight” rating in a research note on Thursday, November 11th. Morgan Stanley upped their target price on GoodRx from $38.00 to $41.00 and gave the company an “equal weight” rating in a research note on Friday, December 17th. Finally, SVB Leerink reduced their target price ...
1/12/2022 AstraZeneca PLC (NASDAQ:AZN) Sees Significant Drop in Short Interest - The Cerbat Gem thecerbatgem.com ... a $54.00 price target for the company. in a report on Tuesday, December 7th. TheStreet cut AstraZeneca from a “b” rating to a “c+” rating in a report on Friday, December 10th. Morgan Stanley reissued an “overweight” rating on shares of AstraZeneca in a report on Monday, November 29th. Finally, Zacks Investment Research raised AstraZeneca from a “sell” rating to a “hold” rating and set ...
1/12/2022 Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Up 2.5% on Analyst Upgrade zolmax.com ... 9th. Royal Bank of Canada lifted their price target on Karyopharm Therapeutics from $8.00 to $9.00 and gave the company a “sector perform” rating in a research report on Thursday, December 9th. Finally, Morgan Stanley cut Karyopharm Therapeutics from an “overweight” rating to an “equal weight” rating and reduced their price target for the company from $27.00 to $10.00 in a research report on Friday, November 19th ...
1/12/2022 Illumina, Inc. Expected to Earn FY2021 Earnings of $5.54 Per Share (NASDAQ:ILMN) - The Cerbat Gem thecerbatgem.com ... the stock. Robert W. Baird reduced their price objective on shares of Illumina from $493.00 to $437.00 and set a “neutral” rating for the company in a research report on Monday, November 8th. Morgan Stanley began coverage on shares of Illumina in a research note on Thursday, January 6th. They set an “equal weight” rating and a $425.00 price objective for the company. Barclays raised shares of Illumina ...
1/12/2022 Hologic, Inc. (NASDAQ:HOLX) Expected to Earn Q1 2023 Earnings of $0.83 Per Share - Stock Observer thestockobserver.com ... for Hologic’s Q2 2023 earnings at $0.84 EPS, Q3 2023 earnings at $0.85 EPS and Q4 2023 earnings at $0.86 EPS.Get Hologic alerts: HOLX has been the topic of several other reports. Morgan Stanley increased their target price on Hologic from $75.00 to $76.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 2nd. Citigroup downgraded Hologic from a “buy” rating ...
1/12/2022 Oak Street Health (NYSE:OSH) Rating Lowered to Market Perform at Cowen dispatchtribunal.com ... November 10th. Truist reduced their target price on shares of Oak Street Health from $72.00 to $55.00 and set a “buy” rating on the stock in a research note on Wednesday, October 13th. Morgan Stanley reaffirmed an “equal weight” rating and set a $33.00 target price (down from $44.00) on shares of Oak Street Health in a research note on Friday, December 17th. Jefferies Financial Group began coverage ...
1/12/2022 Nobilis Health (NYSEAMERICAN:HLTH) Trading Up 3.1% - Slater Sentinel slatersentinel.com ... shares. Zacks Investment Research raised shares of Nobilis Health from a “hold” rating to a “buy” rating and set a $13.00 target price on the stock in a research report on Wednesday. Morgan Stanley started coverage on shares of Nobilis Health in a research report on Tuesday, October 19th. They set an “equal weight” rating and a $12.00 target price on the stock. The Goldman Sachs Group ...
1/12/2022 ShockWave Medical, Inc. (NASDAQ:SWAV) Shares Bought by TD Asset Management Inc. The Markets Daily ... shares of ShockWave Medical by 2,438.5% during the second quarter. Invesco Ltd. now owns 606,503 shares of the company’s stock valued at $115,071,000 after purchasing an additional 582,611 shares in the last quarter. Morgan Stanley raised its stake in shares of ShockWave Medical by 113.8% during the second quarter. Morgan Stanley now owns 354,403 shares of the company’s stock valued at $67,241,000 after purchasing an additional 188,626 shares ...
1/12/2022 Bolt Biotherapeutics (NASDAQ:BOLT) Upgraded at Zacks Investment Research dispatchtribunal.com ... shares of Bolt Biotherapeutics in a report on Thursday, December 9th. Jonestrading restated a buy rating and set a $45.00 target price on shares of Bolt Biotherapeutics in a report on Monday, December 6th. Morgan Stanley lowered Bolt Biotherapeutics from an overweight rating to an equal weight rating in a research note on Thursday, January 6th. Finally, Stifel Nicolaus lifted their price objective on Bolt Biotherapeutics from $19.00 to $34.00 ...
1/12/2022 Biogen (NASDAQ:BIIB) PT Lowered to $328.00 at Needham & Company LLC - The Cerbat Gem thecerbatgem.com ... an outperform rating in a research report on Thursday, October 21st. Wells Fargo & Company raised their target price on shares of Biogen from $250.00 to $284.00 in a research report on Thursday, December 30th. Morgan Stanley dropped their target price on shares of Biogen from $440.00 to $363.00 and set an overweight rating for the company in a research report on Thursday, January 6th. SVB Leerink dropped their target price ...
1/12/2022 Bolt Biotherapeutics (NASDAQ:BOLT) Upgraded by Zacks Investment Research to “Buy” thelincolnianonline.com ... Redwood city, California. “A number of other research analysts also recently commented on the company. SVB Leerink reaffirmed a buy rating on shares of Bolt Biotherapeutics in a report on Thursday, December 9th. Morgan Stanley downgraded Bolt Biotherapeutics from an overweight rating to an equal weight rating in a report on Thursday, January 6th. Stifel Nicolaus raised their price target on Bolt Biotherapeutics from $19.00 to $34.00 and gave ...
1/12/2022 AbbVie's guidance for Skyrizi and Rinvoq lifts remaining overhang - Morgan Stanley Seeking Alpha AbbVie’s guidance for Skyrizi and Rinvoq lifts remaining overhang - Morgan StanleyJan. 12, 2022 10:52 AM ET AbbVie Inc. (ABBV) By: Dulan Lokuwithana , SA News Editor 6 Comments[AbbVie Inc ...
1/12/2022 Amazon Top FANG Stock For 2022 MSN Previous Next Amazon Top FANG Stock For 2022 uk.investing.com 1 hour ago Investing.com © Reuters Amazon Top FANG Stock For 2022 By Sam BougheddaInvesting.com — Amazon.com Inc (NASDAQ:AMZN) shares have climbed 2.44% Tuesday following positive commentary from Morgan Stanley and BofA analysts.Brian Nowak, an analyst at Morgan Stanley , raised his price target on Amazon shares to $4,200 from $4,000, keeping an overweight rating.The analyst told investors in ...